The UK pharmacists’ watchdog has pledged to investigate and ‘take action’ after an undercover BBC investigation exposed illegal and potentially harmful prescribing practices in the country’s aesthetic injectables sector.
Under UK law, botulinum toxin can only be prescribed by a doctor, prescribing nurse or pharmacist, or dentist after a face-to-face consultation. Prescribers must also ensure that the product is supplied to an appropriately qualified and experienced injector for administration.
But BBC reporters posing as beauticians found several pharmacists willing to prescribe Botox for beauticians to use on people who had not been clinically assessed – a direct breach of prescribing standards and patient safety requirements.
This comes amid mounting scrutiny of the UK’s aesthetic market, which has long faced criticism for weak oversight and regulatory gaps.
As part of the BBC sting, an East London pharmacist was filmed selling vials of Botox to an undercover reporter posing as a beautician. He asked the reporter to complete paperwork to create a false patient consultation record and offered to supply additional product under the same prescription.
Other pharmacists were filmed or recorded describing similar workarounds, including falsifying photographs to deceive regulators into believing that face-to-face consultations had occurred.
According to the BBC, the General Pharmaceutical Council (GPhC) said it was continuing to review the evidence for its own investigation.
‘We will take enforcement action against pharmacies, pharmacists and pharmacy technicians when required to protect patient safety,’ said Dionne Spence, Chief Enforcement Officer at the General Pharmaceutical Council (GPhC).
Wider safety breaches and black market supply
The BBC investigation also uncovered potentially dangerous activity beyond community pharmacies, including a nurse offering to sell prescriptions over WhatsApp for cash and a fake doctor selling unlicensed black-market product sourced from overseas.
Spence told the BBC she was ‘very concerned’ and ‘incredibly disappointed’ by these findings. ‘Our guidance is also clear that when providing non-surgical cosmetic medical products such as Botox, there needs to be a physical examination of the person to support a safe prescribing decision,’ she said.
She said the GPhC had already tightened guidance on online supply of medicines and was working closely with the other industry watchdogs to regulate the supply of botulinum toxin prescriptions.
The findings echo the growing policy debate over gaps in oversight, with regulators and policymakers under increasing pressure to close loopholes and strengthen prescribing and delegation rules.
The Department of Health and Social Care confirmed that work is underway on a national licensing scheme designed to protect patients and lift industry standards. The proposed legislation aims to address unsafe practices, including the growing use of prescriptions issued to non-medical injectors.
